Novartis

Isomorphic Labs, the London-based, drug discovery–focused spinout of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to…

Greater availability of African genomic data could lead to medical breakthroughs for the continent’s 1.2 billion people. That’s the driving proposition of 54gene — a U.S. and Nigeria-based startup —…

With a clinical version of PathAI‘s computer vision-based pathology detection service still at least one year from coming to market, the diagnostic technology developer has snagged $60 million in its…

23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test…

Fifty-nine startups took the stage at Y Combinator’s Demo Day 2, and among the highlights were a company that helps developers manage in-app subscriptions; a service that lets you create…

Are you a hacking speed demon of incomparable skill? Then we want you to submit your best hack to the Virtual Hackathon going down at TechCrunch Disrupt San Francisco 2018…

As biotechnology gains prominence among investors, two hubs have emerged as hotbeds of innovation for the resurgent industry. While the two-square-mile patch of South San Francisco bustles with more than 70 biotech…

Google has announced a new licensing deal with big pharmacy corporation Novartis to bring its “smart” contact lenses, with the power to help diabetics track their blood glucose level, to…